title: Combating Tuberculosis Infection: A Forbidding Challenge.
abstract: After 50 years drought, several drugs are looming from the pipeline to combat tuberculosis. They will serve as a boon to the field that has been burdened with primitive, inadequate treatments and drug-resistant bacterial strains. From the decades, due to lack of interest and resources, the field has suffered a lot. Learning from the flaws, scientists have renovated their approaches to the finding of new antitubercular drugs. The first line drugs take about six months or more for the entire treatment. The second line remedy for resistant-tuberculosis requires daily injections which carry severe side effects. Drug resistance remains a constant menace because patients stop the medication once they start feeling better. So new drugs are required to be explored which are effective against tuberculosis especially drug resistant tuberculosis. These drugs need to work well with other drugs as well as with antivirals used for the treatment of human immunodeficiency virus. It is also very important to be considered that the treatments need to be cheap, as tuberculosis primarily affects people more in the developing countries. Further, new drugs must cure the disease in short span of time than the current six to nine month regimen. Recently a few new and potent drugs such as bedaquiline, delamanid, teixobactin have been evolved which may serve as a nice step forward, with a better outcome. Teixobactin, a new antibiotic has been found to have promising action against resistant strains, is also under consideration.
authors.affiliation: Institute of Pharmacy, Nirma University, S. G. Highway, Ahmedabad-382 481, India.
authors.forename: Tejal
authors.initials: T
authors.lastname: Rawal
authors.affiliation: Institute of Pharmacy, Nirma University, S. G. Highway, Ahmedabad-382 481, India.
authors.forename: Shital
authors.initials: S
authors.lastname: Butani
keywords: Tuberculosis; bedaquiline; latent; teixobactin